Back to DRUG
WELLINGTON MANAGEMENT GROUP LLP → DRUG
WELLINGTON MANAGEMENT GROUP LLP DRUG Position History
Bright Minds Biosciences Inc. • Healthcare
Quarters held
18
Latest value
$310K
Q3 2026
Peak value
$5.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $305K |
| Q4 2025 | $48K |
| Q4 2025 | $716K |
| Q1 2026 | $4.4M |
| Q1 2026 | $101K |
| Q1 2026 | $608K |
| Q1 2026 | $4.5M |
| Q1 2026 | $388K |
| Q2 2026 | $5.4M |
| Q2 2026 | $131K |
| Q2 2026 | $733K |
| Q2 2026 | $5.4M |
| Q2 2026 | $305K |
| Q3 2026 | $4.8M |
| Q3 2026 | $118K |
| Q3 2026 | $697K |
| Q3 2026 | $5.1M |
| Q3 2026 | $310K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $310K | 6.2K | — | — |
| Q3 2026 | $5.1M | 102.8K | — | — |
| Q3 2026 | $697K | 14.0K | — | — |
| Q3 2026 | $118K | 2.4K | — | — |
| Q3 2026 | $4.8M | 95.9K | — | — |
| Q2 2026 | $305K | 4.3K | — | — |
| Q2 2026 | $5.4M | 77.3K | — | — |
| Q2 2026 | $733K | 10.4K | — | — |
| Q2 2026 | $131K | 1.9K | — | — |
| Q2 2026 | $5.4M | 77.4K | — | — |
| Q1 2026 | $388K | 5.3K | — | — |
| Q1 2026 | $4.5M | 61.6K | — | — |
| Q1 2026 | $608K | 8.3K | — | — |
| Q1 2026 | $101K | 1.4K | — | — |
| Q1 2026 | $4.4M | 60.0K | — | — |
| Q4 2025 | $716K | 9.2K | — | — |
| Q4 2025 | $48K | 612 | — | — |
| Q4 2025 | $305K | 3.9K | — | — |